Clinical Trials
4 trialsNCT01032850 2021-06-02
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT02042443 2017-09-12
S1310
National Cancer Institute (NCI)
Phase 2 Completed
NCT00483405 2017-07-12
NRR
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00787787 2017-06-01
Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer
University of Washington
Phase 2 Terminated